Nasal vestibule squamous papilloma

Summary

Nasal vestibule squamous papilloma (MONDO:0003753) is a disease. A subtype of squamous papilloma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	nasal vestibule squamous papilloma
Mondo ID	MONDO:0003753
DOID	DOID:6059
NCIT	C4369
SNOMED CT	232364006
UMLS	C0339826
MedGen	90945
Anatomy (UBERON)	UBERON:0000402
Is cancer (heuristic)	no

Also known as: nasal vestibule papilloma · nasal vestibule squamous papilloma · papilloma of nasal vestibule · papilloma of the nasal vestibule · squamous papilloma of nasal vestibule · squamous papilloma of the nasal vestibule

Disease family

This is a subtype of squamous papilloma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › epithelial neoplasm › papillary epithelial neoplasm › papilloma › squamous papilloma › nasal vestibule squamous papilloma

Related subtypes (7): larynx squamous papilloma, bladder squamous papilloma, vaginal squamous papilloma, vestibular papilloma, squamous cell skin papilloma, cervix squamous papilloma, esophagus squamous cell papilloma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.